APELLIS PHARMACEUTICALS INC. - COMMON STOCK
27.40
14-February-25 15:45:00
15 minutes delayed
Stocks
-0.06
-0.22%
Today's range
27.02 - 28.23
ISIN
N/A
Source
NASDAQ
-
17 Apr 2023 06:00:00 By Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 Apr 2023 15:05:00 By Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 Mar 2023 15:05:00 By Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
01 Mar 2023 06:00:02 By Nasdaq GlobeNewswire
-
27 Feb 2023 16:19:35 By Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
22 Feb 2023 20:48:09 By Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
22 Feb 2023 06:22:35 By Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results
21 Feb 2023 15:14:10 By Nasdaq GlobeNewswire
-
17 Feb 2023 15:06:06 By Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13 Feb 2023 15:05:00 By Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 Jan 2023 15:05:00 By Nasdaq GlobeNewswire
-
Apellis Appoints Leading Retina Specialist Dr. Caroline Baumal as Chief Medical Officer
05 Jan 2023 06:00:00 By Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference
03 Jan 2023 06:00:00 By Nasdaq GlobeNewswire
-
16 Dec 2022 06:00:00 By Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07 Dec 2022 15:05:00 By Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
22 Nov 2022 15:05:00 By Nasdaq GlobeNewswire
-
18 Nov 2022 06:00:00 By Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Reports Third Quarter 2022 Financial Results
07 Nov 2022 15:05:02 By Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 Nov 2022 15:05:00 By Nasdaq GlobeNewswire
-
03 Nov 2022 15:01:01 By Nasdaq GlobeNewswire